29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cytosolic chloride ion is a key factor in lysosomal acidification and function of autophagy in human gastric cancer cell

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of the present study was to clarify roles of cytosolic chloride ion (Cl ) in regulation of lysosomal acidification [intra-lysosomal pH (pH lys)] and autophagy function in human gastric cancer cell line (MKN28). The MKN28 cells cultured under a low Cl condition elevated pH lys and reduced the intra-lysosomal Cl concentration ([Cl ] lys) via reduction of cytosolic Cl concentration ([Cl ] c), showing abnormal accumulation of LC3II and p62 participating in autophagy function (dysfunction of autophagy) accompanied by inhibition of cell proliferation via G 0/G 1 arrest without induction of apoptosis. We also studied effects of direct modification of H + transport on lysosomal acidification and autophagy. Application of bafilomycin A1 (an inhibitor of V-type H +-ATPase) or ethyl isopropyl amiloride [EIPA; an inhibitor of Na +/H + exchanger (NHE)] elevated pH lys and decreased [Cl ] lys associated with inhibition of cell proliferation via induction of G 0/G 1 arrest similar to the culture under a low Cl condition. However, unlike low Cl condition, application of the compound, bafilomycin A1 or EIPA, induced apoptosis associated with increases in caspase 3 and 9 without large reduction in [Cl ] c compared with low Cl condition. These observations suggest that the lowered [Cl ] c primarily causes dysfunction of autophagy without apoptosis via dysfunction of lysosome induced by disturbance of intra-lysosomal acidification. This is the first study showing that cytosolic Cl is a key factor of lysosome acidification and autophagy.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Pancreatic cancers require autophagy for tumor growth.

          Macroautophagy (autophagy) is a regulated catabolic pathway to degrade cellular organelles and macromolecules. The role of autophagy in cancer is complex and may differ depending on tumor type or context. Here we show that pancreatic cancers have a distinct dependence on autophagy. Pancreatic cancer primary tumors and cell lines show elevated autophagy under basal conditions. Genetic or pharmacologic inhibition of autophagy leads to increased reactive oxygen species, elevated DNA damage, and a metabolic defect leading to decreased mitochondrial oxidative phosphorylation. Together, these ultimately result in significant growth suppression of pancreatic cancer cells in vitro. Most importantly, inhibition of autophagy by genetic means or chloroquine treatment leads to robust tumor regression and prolonged survival in pancreatic cancer xenografts and genetic mouse models. These results suggest that, unlike in other cancers where autophagy inhibition may synergize with chemotherapy or targeted agents by preventing the up-regulation of autophagy as a reactive survival mechanism, autophagy is actually required for tumorigenic growth of pancreatic cancers de novo, and drugs that inactivate this process may have a unique clinical utility in treating pancreatic cancers and other malignancies with a similar dependence on autophagy. As chloroquine and its derivatives are potent inhibitors of autophagy and have been used safely in human patients for decades for a variety of purposes, these results are immediately translatable to the treatment of pancreatic cancer patients, and provide a much needed, novel vantage point of attack.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Akt, FoxO and regulation of apoptosis.

            Forkhead box O (FoxO) transcription factors are downstream targets of the serine/threonine protein kinase B (PKB)/Akt. The Akt kinase regulates processes of cellular proliferation and survival. Phosphorylation of FoxOs by Akt inhibits transcriptional functions of FoxOs and contributes to cell survival, growth and proliferation. Emerging evidence suggests involvement of FoxOs in diverse intracellular signaling pathways with critical roles in a number of physiological as well as pathological conditions including cancer. The FoxO signaling is regulated by their interactions with other intracellular proteins as well as their post-translational modifications such as phosphorylation. FoxOs promote cell growth inhibitory and/or apoptosis signaling by either inducing expression of multiple pro-apoptotic members of the Bcl2-family of mitochondria-targeting proteins, stimulating expression of death receptor ligands such as Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), or enhancing levels of various cyclin-dependent kinase inhibitors (CDKIs). Coupled with their ability to cross-talk with p53, FoxOs represent an important class of tumor suppressors in a variety of cancers. This review summarizes our current understanding of mechanisms by which Akt and FoxOs regulate cell growth and survival that in turn offers opportunities for development of novel strategies to combat cancer. This article is part of a Special Issue entitled: P13K-AKT-FOxO axis in cancer and aging. 2011 Elsevier B.V. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              How to interpret LC3 immunoblotting.

              Microtubule-associated protein light chain 3 (LC3) is now widely used to monitor autophagy. One approach is to detect LC3 conversion (LC3-I to LC3-II) by immunoblot analysis because the amount of LC3-II is clearly correlated with the number of autophagosomes. However, LC3-II itself is degraded by autophagy, making interpretation of the results of LC3 immunoblotting problematic. Furthermore, the amount of LC3 at a certain time point does not indicate autophagic flux, and therefore, it is important to measure the amount of LC3-II delivered to lysosomes by comparing LC3-II levels in the presence and absence of lysosomal protease inhibitors. Another problem with this method is that LC3-II tends to be much more sensitive to be detected by immunoblotting than LC3-I. Accordingly, simple comparison of LC3-I and LC3-II, or summation of LC3-I and LC3-II for ratio determinations, may not be appropriate, and rather, the amount of LC3-II can be compared between samples.
                Bookmark

                Author and article information

                Journal
                J Cell Mol Med
                J. Cell. Mol. Med
                jcmm
                Journal of Cellular and Molecular Medicine
                John Wiley & Sons, Ltd (Chichester, UK )
                1582-1838
                1582-4934
                June 2014
                12 April 2014
                : 18
                : 6
                : 1124-1133
                Affiliations
                [a ]Department of Molecular Cell Physiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine Kyoto, Japan
                [b ]Japan Institute for Food Education and Health, Heian Jogakuin (St. Agnes') University Kyoto, Japan
                [c ]Department of Orthopaedic Surgery, Kyoto Kujo Hospital Kyoto, Japan
                [d ]Department of Bio-Ionomics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine Kyoto, Japan
                [e ]Saisei Mirai Clinics Moriguchi, Japan
                [f ]Department of Respiratory Medicine, Shanghai Respiratory Research Institute, Fudan University Zhongshan Hospital Shanghai, China
                Author notes
                * Correspondence to: Dr. Shigekuni HOSOGI, M.D., Ph.D. and Prof. Yoshinori MARUNAKA, M.D., Ph.D., Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan., Tel.: +81-75-251-5311, Fax: +81-75-251-0295, E-mails: hosogi@ 123456koto.kpu-m.ac.jp for Shigekuni Hosogi; marunaka@ 123456koto.kpum.ac.jp for Yoshinori Marunaka
                Article
                10.1111/jcmm.12257
                4508152
                24725767
                7e8eb1bf-cd35-4064-b7bc-4875126149ea
                © 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 September 2013
                : 22 January 2014
                Categories
                Original Articles

                Molecular medicine
                autophagy,chloride ion,lysosome,ph,apoptosis
                Molecular medicine
                autophagy, chloride ion, lysosome, ph, apoptosis

                Comments

                Comment on this article